Immune Activation and Microbial Translocation Markers in HIV-Exposed Uninfected Malawian Infants in the First Year of Life.


Journal

Journal of tropical pediatrics
ISSN: 1465-3664
Titre abrégé: J Trop Pediatr
Pays: England
ID NLM: 8010948

Informations de publication

Date de publication:
01 12 2019
Historique:
pubmed: 22 4 2019
medline: 1 7 2020
entrez: 22 4 2019
Statut: ppublish

Résumé

HIV-exposed uninfected (HEU) infants show a high rate of morbidity. We aimed to investigate on biomarkers of immune activation/microbial translocation in HEU infants, evaluating the impact that infections/malnutrition can have on biomarker levels during the first year of life. Clinical data of 72 Malawian infants were recorded monthly and correlated with levels of soluble CD14 (sCD14), lipopolysaccharide-binding protein (LBP) and intestinal fatty acid-binding protein (I-FABP), analyzed longitudinally. Levels of sCD14 and LBP showed a significant age-related increase. Higher levels of LBP (19.4 vs. 15.2 μg/ml) were associated with stunting, affecting 30% of the infants. The association remained statistically significant after adjusting for cytomegalovirus acquisition, malaria and respiratory infections (p = 0.031). I-FABP levels were significantly increased in infants experiencing gastrointestinal infections (1442.8 vs. 860.0 pg/ml, p = 0.018). We provide evidence that stunting is associated with an enhanced inflammatory response to microbial products in HEU children, suggesting that malnutrition status should be taken into consideration to better understand the alteration of the immune profile of HEU infants living in poor socioeconomic settings.

Sections du résumé

BACKGROUND
HIV-exposed uninfected (HEU) infants show a high rate of morbidity. We aimed to investigate on biomarkers of immune activation/microbial translocation in HEU infants, evaluating the impact that infections/malnutrition can have on biomarker levels during the first year of life.
METHODS
Clinical data of 72 Malawian infants were recorded monthly and correlated with levels of soluble CD14 (sCD14), lipopolysaccharide-binding protein (LBP) and intestinal fatty acid-binding protein (I-FABP), analyzed longitudinally.
RESULTS
Levels of sCD14 and LBP showed a significant age-related increase. Higher levels of LBP (19.4 vs. 15.2 μg/ml) were associated with stunting, affecting 30% of the infants. The association remained statistically significant after adjusting for cytomegalovirus acquisition, malaria and respiratory infections (p = 0.031). I-FABP levels were significantly increased in infants experiencing gastrointestinal infections (1442.8 vs. 860.0 pg/ml, p = 0.018).
CONCLUSION
We provide evidence that stunting is associated with an enhanced inflammatory response to microbial products in HEU children, suggesting that malnutrition status should be taken into consideration to better understand the alteration of the immune profile of HEU infants living in poor socioeconomic settings.

Identifiants

pubmed: 31006009
pii: 5475883
doi: 10.1093/tropej/fmz022
doi:

Substances chimiques

Acute-Phase Proteins 0
Anti-Retroviral Agents 0
Biomarkers 0
Carrier Proteins 0
Fatty Acid-Binding Proteins 0
Lipopolysaccharide Receptors 0
Membrane Glycoproteins 0
lipopolysaccharide-binding protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

617-625

Informations de copyright

© The Author(s) [2019]. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Silvia Baroncelli (S)

National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.

Clementina Maria Galluzzo (CM)

National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.

Giuseppe Liotta (G)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

Mauro Andreotti (M)

National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.

Sandro Mancinelli (S)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

Robert Mphwere (R)

DREAM Program, Community of S. Egidio, Blantyre, Malawi.

Enok Bokola (E)

DREAM Program, Community of S. Egidio, Blantyre, Malawi.

Roberta Amici (R)

National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.

Maria Cristina Marazzi (MC)

Department of Human Sciences, LUMSA University, Rome, Italy.

Leonardo Palombi (L)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

Lucia Palmisano (L)

National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.

Marina Giuliano (M)

National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH